Please find enclosed herewith a statement of non-applicability of deviation or variation under Regulation 32 of SEBI(LODR) Regulations 2015 for the quarter ended 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Elango Industries Limited has submitted a compliance filing to BSE confirming that there was no deviation or variation in the utilisation of funds raised through its Initial Public Offer (IPO). The company stated that the IPO proceeds were used for the purposes as disclosed in the prospectus, and therefore the Statement of Deviation or Variation is not applicable to the company. This filing is for the quarter ended 31st March 2026. The company secretary Nitesh Kumar Sharma signed the submission on 28th May 2026.
This is a routine regulatory compliance filing with no direct impact on the stock. It provides assurance to investors that the IPO funds have been deployed as intended, which is a positive indicator of corporate governance.